Harrow, Inc. SEC filings HROW

Harrow, Inc. has 868 filings in SEC EDGAR's recent list, going back to Jul 21, 2006. Its latest annual report, Form 10-K, was filed on Mar 2, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 10, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 5, 2026 (material agreement, acquisition or sale of assets, regulation fd disclosure). The company's fiscal year ends on December 31.

Harrow, Inc. SEC filings
Form Description Filed Period
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 27, 2026 —
8-K Current report
Material agreement, Acquisition or sale of assets, Regulation FD disclosure
Oct 5, 2026 Oct 1, 2026
8-K Current report
Officer or director change
Sep 4, 2026 Sep 4, 2026
144 Notice of proposed sale Aug 21, 2026 —
4 Insider transaction Aug 17, 2026 Aug 14, 2026
10-Q Quarterly report Aug 10, 2026 Jun 30, 2026
8-K Current report
Results of operations, Regulation FD disclosure
Aug 10, 2026 Aug 10, 2026
8-K Current report
Material agreement, Regulation FD disclosure
Aug 6, 2026 Aug 3, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 31, 2026 —
4 Insider transaction Jun 22, 2026 Jun 18, 2026
4 Insider transaction Jun 22, 2026 Jun 18, 2026
4 Insider transaction Jun 22, 2026 Jun 18, 2026
8-K Current report
Shareholder vote results
Jun 22, 2026 Jun 18, 2026
8-K Current report
Regulation FD disclosure
Jun 3, 2026 Jun 3, 2026
4 Insider transaction May 19, 2026 May 18, 2026
4 Insider transaction May 19, 2026 May 18, 2026
4 Insider transaction May 18, 2026 May 15, 2026
4 Insider transaction May 15, 2026 May 14, 2026
4 Insider transaction May 15, 2026 May 14, 2026
10-Q Quarterly report May 11, 2026 Mar 31, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 11, 2026 —
8-K Current report
Results of operations, Regulation FD disclosure
May 11, 2026 May 11, 2026
DEFA14A Additional proxy material Apr 24, 2026 —
DEF 14A Proxy statement Apr 24, 2026 Dec 31, 2025
8-K Current report
Material agreement, New debt, Other events
Mar 27, 2026 Mar 24, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 27, 2026 —
8-K Current report
Other events
Mar 24, 2026 Mar 24, 2026
8-K Current report
Other events
Mar 24, 2026 Mar 24, 2026
SCHEDULE 13G Ownership over 5% (passive) Mar 11, 2026 —
8-K Current report
Regulation FD disclosure
Mar 10, 2026 Mar 10, 2026
4 Insider transaction Mar 5, 2026 Mar 3, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
10-K Annual report Mar 2, 2026 Dec 31, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Mar 2, 2026 Mar 2, 2026
4 Insider transaction Feb 2, 2026 Jan 30, 2026
3 Initial insider ownership Feb 2, 2026 Jan 30, 2026
8-K Current report
Results of operations, Officer or director change
Feb 2, 2026 Jan 30, 2026
4 Insider transaction Jan 8, 2026 Jan 6, 2026
4 Insider transaction Dec 16, 2025 Dec 12, 2025
4 Insider transaction Dec 16, 2025 Dec 12, 2025
8-K Current report
Acquisition or sale of assets, Unregistered share sale, Other events
Nov 18, 2025 Nov 17, 2025
10-Q Quarterly report Nov 10, 2025 Sep 30, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Nov 10, 2025 Aug 11, 2025
3 Initial insider ownership Oct 10, 2025 Oct 6, 2025
25-NSE Delisting notice Oct 10, 2025 —
25-NSE Delisting notice Oct 8, 2025 —
8-K Current report
Officer or director change, Regulation FD disclosure
Oct 6, 2025 Oct 6, 2025
8-K/A Amended current report Oct 1, 2025 Sep 24, 2025
8-K Current report
Material agreement, New debt
Sep 29, 2025 Sep 26, 2025
8-K Current report
Regulation FD disclosure
Sep 26, 2025 Sep 26, 2025
8-K Current report
Material agreement, Unregistered share sale, Other events
Sep 26, 2025 Sep 24, 2025
8-K Current report
Auditor change
Sep 19, 2025 Sep 17, 2025
8-K Current report
Material agreement, New debt, Other events
Sep 12, 2025 Sep 8, 2025
4 Insider transaction Sep 9, 2025 Sep 1, 2025
3 Initial insider ownership Sep 9, 2025 Sep 1, 2025
8-K Current report
Other events
Sep 9, 2025 Sep 8, 2025
8-K Current report
Material agreement, New debt, Other events
Sep 8, 2025 Sep 5, 2025
8-K Current report
Officer or director change, Bylaw or fiscal year change
Aug 25, 2025 Aug 21, 2025
10-Q Quarterly report Aug 11, 2025 Jun 30, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Aug 11, 2025 Aug 11, 2025
4 Insider transaction Jul 23, 2025 Jul 21, 2025
8-K Current report
Other events
Jul 17, 2025 Jul 17, 2025
4 Insider transaction Jul 1, 2025 Jul 1, 2025
4 Insider transaction Jul 1, 2025 Jul 1, 2025
4 Insider transaction Jun 24, 2025 Jun 20, 2025
4 Insider transaction Jun 24, 2025 Jun 20, 2025
4 Insider transaction Jun 24, 2025 Jun 20, 2025
S-8 Employee stock plan registration Jun 20, 2025 —
8-K Current report
Shareholder vote results
Jun 20, 2025 Jun 18, 2025
4 Insider transaction Jun 11, 2025 Jun 9, 2025
8-K Current report
Other events
Jun 9, 2025 Jun 9, 2025
4 Insider transaction Jun 5, 2025 Jun 3, 2025
4 Insider transaction May 14, 2025 May 12, 2025
4/A Filing May 14, 2025 Mar 18, 2025
4/A Filing May 14, 2025 Mar 24, 2025
10-Q Quarterly report May 8, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 8, 2025 May 8, 2025
DEFA14A Additional proxy material Apr 25, 2025 —
DEF 14A Proxy statement Apr 25, 2025 Dec 31, 2024
4 Insider transaction Apr 7, 2025 Apr 3, 2025
4 Insider transaction Apr 7, 2025 Apr 3, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Apr 7, 2025 —
4 Insider transaction Apr 7, 2025 Apr 3, 2025
10-K Annual report Mar 27, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 27, 2025 Mar 27, 2025
4 Insider transaction Mar 26, 2025 Mar 24, 2025
4 Insider transaction Mar 20, 2025 Mar 18, 2025
NT 10-K Filing Mar 17, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 17, 2025 Mar 17, 2025
4 Insider transaction Mar 4, 2025 Feb 28, 2025
4 Insider transaction Jan 24, 2025 Jan 22, 2025
8-K Current report
Officer or director change
Jan 21, 2025 Jan 17, 2025
4 Insider transaction Jan 8, 2025 Jan 6, 2025
3 Initial insider ownership Jan 8, 2025 Jan 6, 2025
SC 13G/A Amended ownership over 5% (passive) Dec 5, 2024 —
10-Q Quarterly report Nov 14, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 14, 2024 Nov 13, 2024
8-K Current report
Material agreement, New debt
Oct 28, 2024 Oct 25, 2024
SC 13G/A Amended ownership over 5% (passive) Oct 8, 2024 —
4 Insider transaction Sep 13, 2024 Sep 11, 2024
8-K Current report
Regulation FD disclosure
Sep 9, 2024 Sep 9, 2024
10-Q Quarterly report Aug 7, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 7, 2024 Aug 7, 2024
8-K Current report
Auditor change
Jun 26, 2024 Jun 24, 2024
4 Insider transaction Jun 17, 2024 Jun 14, 2024
4 Insider transaction Jun 17, 2024 Jun 14, 2024
4 Insider transaction Jun 17, 2024 Jun 14, 2024
4 Insider transaction Jun 17, 2024 Jun 14, 2024
8-K Current report
Shareholder vote results
Jun 17, 2024 Jun 14, 2024
10-Q Quarterly report May 13, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 13, 2024 May 13, 2024
SC 13D/A Amended ownership over 5% (active) Apr 30, 2024 —
DEFA14A Additional proxy material Apr 26, 2024 —
DEF 14A Proxy statement Apr 26, 2024 Apr 26, 2024
4 Insider transaction Apr 25, 2024 Apr 25, 2024
4 Insider transaction Apr 24, 2024 Apr 23, 2024
4 Insider transaction Apr 19, 2024 Apr 19, 2024
4 Insider transaction Mar 28, 2024 Mar 28, 2024
4 Insider transaction Mar 25, 2024 Mar 22, 2024
4 Insider transaction Mar 22, 2024 Mar 20, 2024
8-K Current report
Other events
Mar 21, 2024 Mar 20, 2024
8-K Current report
Other events
Mar 20, 2024 Mar 19, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Mar 19, 2024 Mar 19, 2024
10-K Annual report Mar 19, 2024 Dec 31, 2023
4 Insider transaction Mar 6, 2024 Mar 1, 2024
4 Insider transaction Feb 21, 2024 Feb 20, 2024
4 Insider transaction Feb 21, 2024 Feb 20, 2024
4 Insider transaction Feb 21, 2024 Feb 20, 2024
8-K Current report
Other events
Feb 15, 2024 Feb 15, 2024
SC 13G/A Amended ownership over 5% (passive) Feb 13, 2024 —
SC 13G Ownership over 5% (passive) Feb 13, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 9, 2024 —
4 Insider transaction Feb 8, 2024 Feb 7, 2024
4 Insider transaction Feb 8, 2024 Feb 7, 2024
4 Insider transaction Jan 30, 2024 Jan 26, 2024
4 Insider transaction Jan 30, 2024 Jan 26, 2024
3 Initial insider ownership Jan 30, 2024 Jan 26, 2024
3 Initial insider ownership Jan 30, 2024 Jan 26, 2024
8-K Current report
Officer or director change
Jan 29, 2024 Jan 26, 2024
SC 13G Ownership over 5% (passive) Jan 29, 2024 —
SC 13G Ownership over 5% (passive) Jan 9, 2024 —
8-K Current report
Agreement ended, Officer or director change, Other events
Jan 3, 2024 Dec 28, 2023
SC 13G Ownership over 5% (passive) Nov 24, 2023 —
4 Insider transaction Nov 16, 2023 Nov 16, 2023
4 Insider transaction Nov 16, 2023 Sep 19, 2023
4 Insider transaction Nov 14, 2023 Nov 10, 2023
10-Q Quarterly report Nov 13, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 13, 2023 Nov 13, 2023
8-K Current report
Officer or director change
Nov 3, 2023 Nov 3, 2023
8-K Current report
Bylaw or fiscal year change
Sep 29, 2023 Sep 29, 2023
4 Insider transaction Sep 20, 2023 Sep 19, 2023
SC 13D/A Amended ownership over 5% (active) Aug 18, 2023 —
4 Insider transaction Aug 15, 2023 Aug 14, 2023
4 Insider transaction Aug 15, 2023 Aug 14, 2023
10-Q Quarterly report Aug 9, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 9, 2023 Aug 9, 2023
8-K Current report
Material agreement, Regulation FD disclosure
Jul 21, 2023 Jul 18, 2023
4 Insider transaction Jul 20, 2023 Jul 18, 2023
4 Insider transaction Jul 20, 2023 Jul 18, 2023
4 Insider transaction Jul 20, 2023 Jul 18, 2023
424B5 Prospectus supplement Jul 19, 2023 —
424B5 Prospectus supplement Jul 18, 2023 —
8-K Current report
Material agreement, Results of operations, Regulation FD disclosure, Other events
Jul 18, 2023 Jul 18, 2023
4 Insider transaction Jun 23, 2023 Jun 21, 2023
4 Insider transaction Jun 23, 2023 Jun 21, 2023
4 Insider transaction Jun 23, 2023 Jun 21, 2023
4 Insider transaction Jun 23, 2023 Jun 21, 2023
8-K Current report
Shareholder vote results
Jun 23, 2023 Jun 21, 2023
10-Q Quarterly report May 11, 2023 Mar 31, 2023
8-K Current report
Results of operations, Regulation FD disclosure
May 11, 2023 May 11, 2023
DEFA14A Additional proxy material Apr 28, 2023 —
DEF 14A Proxy statement Apr 28, 2023 Apr 28, 2023
4 Insider transaction Apr 4, 2023 Apr 3, 2023
4 Insider transaction Apr 4, 2023 Apr 3, 2023
4 Insider transaction Apr 4, 2023 Mar 31, 2023
8-K Current report
Material agreement, Agreement ended, New debt, Other events
Mar 28, 2023 Mar 27, 2023
10-K Annual report Mar 23, 2023 Dec 31, 2022
8-K Current report
Results of operations
Mar 23, 2023 Mar 23, 2023
8-K Current report
Acquisition or sale of assets, Other events
Jan 23, 2023 Jan 20, 2023
SC 13G/A Amended ownership over 5% (passive) Jan 20, 2023 —
8-K Current report
Other events
Jan 12, 2023 Jan 11, 2023
4 Insider transaction Jan 3, 2023 Jan 2, 2023
4 Insider transaction Jan 3, 2023 Jan 2, 2023
4 Insider transaction Dec 23, 2022 Dec 22, 2022
4 Insider transaction Dec 23, 2022 Dec 22, 2022
4 Insider transaction Dec 23, 2022 Dec 21, 2022
4 Insider transaction Dec 23, 2022 Dec 22, 2022
CERT Filing Dec 21, 2022 —
8-A12B Filing Dec 20, 2022 —
8-K Current report
Material agreement, New debt
Dec 20, 2022 Dec 14, 2022
424B5 Prospectus supplement Dec 19, 2022 —
305B2 Filing Dec 16, 2022 —
8-K Current report
Material agreement, Regulation FD disclosure, Other events
Dec 16, 2022 Dec 13, 2022
FWP Free writing prospectus Dec 16, 2022 —
424B5 Prospectus supplement Dec 14, 2022 —
4 Insider transaction Dec 14, 2022 Dec 14, 2022
8-K Current report
Regulation FD disclosure
Dec 14, 2022 Dec 14, 2022
8-K Current report
Material agreement, Other events
Dec 14, 2022 Dec 13, 2022
424B5 Prospectus supplement Dec 14, 2022 —
10-Q Quarterly report Nov 14, 2022 Sep 30, 2022

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
HROW (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Nashville, TN
SEC filer status
Large accelerated filer
SEC CIK
1360214
Former names
HARROW HEALTH, INC. (until Sep 20, 2023); Imprimis Pharmaceuticals, Inc. (until Dec 17, 2018); TRANSDEL PHARMACEUTICALS INC (until Feb 27, 2012); Bywater Resources, Inc (until Sep 12, 2007)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.